Oxymetazoline Hydrochloride Eye-Drops as Treatment for Myasthenia Gravis-Related Ptosis: A Description of Two Cases

In this article, we described two patients with myasthenia gravis-related ptosis who experienced sustained improvement with the use of oxymetazoline hydrochloride ophthalmic solution 0.1%. Despite the commonly used treatments for ptosis in myasthenia gravis (MG), such as acetylcholinesterase inhibit...

Descripción completa

Detalles Bibliográficos
Autores principales: Taha, Mohamed, Li, Yuebing, Morren, John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10111874/
https://www.ncbi.nlm.nih.gov/pubmed/37082493
http://dx.doi.org/10.7759/cureus.36351

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10111874/
https://www.ncbi.nlm.nih.gov/pubmed/37082493
http://dx.doi.org/10.7759/cureus.36351

Ejemplares similares